Charles River Laboratories International Inc Receivables Turnover Ratio (CRL), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Charles River Laboratories International inc   (NYSE: CRL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Charles River Laboratories International Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Charles River Laboratories International Inc 's ability to collect accounts receivable sequentially worsen to 5.37, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Charles River Laboratories International Inc 's Accounts Receivable average collection period in the Sep 26 2026 quarter, has increased to 68 days, from 67 days, in the Jun 27 2026 quarter.

If we take a look into Healthcare sector 269 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1913, from overall ranking in the second quarter 2026 at 2375.

What is Receivable Turnover Ratio?
What is Charles River Laboratories International Inc Selling?


What is Receivable Turnover Ratio?





CRL Receivables Turnover Ratio (Sep 26 2026)
III. Quarter
(Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 27 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
Y / Y Receivable Change 3.28 % 3.58 % -7.45 % -1.67 % -2.62 %
Y / Y Revenue Change -2.2 % -2.72 % 1.18 % -0.83 % -0.49 %
Receivable Turnover Ratio (TTM) 5.37 5.44 5.53 5.41 5.4
CRL's Total Ranking # 1913 # 2375 # 2231 # 1204 #
Accounts Receivable average collection period days 68 67 66 67 68
Seq. Receivable Change -4.59 % 13.53 % -1.21 % -3.49 % -4.31 %
Seq. Revenue Change -2.13 % 0.83 % 0.16 % -1.06 % -2.64 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 20
Healthcare Sector # 270
Overall Market # 1913

Receivable Turnover Ratio Statistics
High Average Low
0.72 0.58 -0.35
(Jun 28 2014)   (Sep 28 2013)






Financial Statements
Charles River Laboratories International Inc 's Accounts Receivable $ 759 Millions Visit CRL's Balance sheet
Charles River Laboratories International Inc 's Sales TTM $ 3,977 Millions Visit CRL's Income Statement
Sources of CRL's Revenues Visit CRL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CRL's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CRL's Growth Rates CRL's Roa CRL's Inventory Turnover Ratio CRL's Dividend Comparisons
CRL's Profitability Ratios CRL's Roi CRL's Asset Turnover Ratio CRL's Dividend Growth
CRL's Valuation Ratios CRL's Roe CRL's Financial Strength Ratios CRL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 26 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 26 2026 Receivable at quarter ending Sep 26 2026
Amneal Pharmaceuticals Inc   14.24 $ 3,196.184  Millions$ 224.488  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Precipio inc   13.38 $ 27.762  Millions$ 2.075  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Gossamer Bio Inc   11.37 $ 78.423  Millions$ 6.896  Millions
Icu Medical Inc  11.32 $ 2,183.556  Millions$ 192.845  Millions
Mannkind Corporation  10.97 $ 413.370  Millions$ 37.686  Millions
Lensar Inc   10.64 $ 60.079  Millions$ 5.645  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Voyager Therapeutics Inc   9.84 $ 25.108  Millions$ 2.551  Millions
Myomo Inc   9.66 $ 47.775  Millions$ 4.947  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Co diagnostics Inc   9.12 $ 0.859  Millions$ 0.094  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Lexicon Pharmaceuticals Inc   8.77 $ 38.537  Millions$ 4.396  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Avita Medical Inc   8.65 $ 84.683  Millions$ 9.795  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Acadia Pharmaceuticals Inc   8.46 $ 1,202.301  Millions$ 142.117  Millions
Novavax inc   8.33 $ 411.649  Millions$ 49.414  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions

Date modified: 2026-11-05T14:33:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.